Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : Jul 23, 2019 06:36 PM IST | Source: PTI

Strides Pharma gets EIR from US regulator for Bengaluru facility

'The company's formulations facility in Bengaluru, which was inspected by the United States Food and Drug Administration (USFDA) in May 2019, has received the EIR, thereby confirming the successful closure of the inspections,' the company said in a BSE filing.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Strides Pharma Science on July 23 said it has received US regulator FDA's establishment inspection report (EIR) for its formulations facility in Bengaluru.

"The company's formulations facility in Bengaluru, which was inspected by the United States Food and Drug Administration (USFDA) in May 2019, has received the EIR, thereby confirming the successful closure of the inspections," the company said in a BSE filing.

Shares of the company declined 2.27 per cent to close at Rs 342.10 apiece on the BSE.

Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.

Close
First Published on Jul 23, 2019 06:35 pm
Sections
Follow us on